Figure 6From: Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes Quantification of RNAi (black bars) and cell survival rates (gray bars) of HER2-positive SKBR3 (A) and HER2-negative HeLa (B) cells treated by negative siRNA combined with RNAiMAX, LPs and Z HER2 -BNC/LP complex (final conc. 25Â nM as siRNA). Back to article page